FDA Warns Prolia May Cause Severe Low Blood Calcium Levels
The FDA began investigating a link between side effects of Prolia and hypocalcemia in November 2022, following adverse reports from dialysis patients.
The FDA began investigating a link between side effects of Prolia and hypocalcemia in November 2022, following adverse reports from dialysis patients.
Researchers are calling for improved bone density screening for patients taking anti-seizure medications due to epilepsy.
Prolia side effects may increase the risk of dangerously low calcium levels in the blood of individuals undergoing dialysis treatment, according to interim findings of an ongoing study
The findings support previous studies which have linked Prolia discontinuation to an increased risk in bone fractures, though this is one of the first cases detected in a bone cancer patient.